downtoearth-subscribe

Business models of the future?

  • 30/03/2005

India is a country hard to slot; neither rich nor poor, neither developing nor developed. This is best seen in the debate on patent protection in the country. One group of industry, which caters to the domestic markets and uses process patents to increase its market share, believes that the current amendment will devastate its plans. The other group wants the amendment as it will protect its r&d investment and partnerships with big pharma. This group hopes to take advantage of the new product patent regime by discovering new molecules and new ways of administering drugs, known as new drug delivery systems, acquire patents on the new products they develop and remain competitive.

But in actual fact, India still spends a pittance on r&d. According to Cipla head Y K Hamied, while India, as a nation, spent us $3 billion last year on all its r&d expenditure

Related Content